COMPOSITION FOR PREVENTING OR TREATING TH17-MEDIATED DISEASES COMPRISING POLY-GAMMA-GLUTAMIC ACID

摘要

The present invention relates to a pharmaceutical use of poly-gamma-glutamic acid for the prevention and treatment of Th17-mediated diseases, and provides a pharmaceutical composition for the prevention or treatment of Th17-mediated diseases containing the poly-gamma-glutamic acid as an active component. The pharmaceutical composition controls the differentiation of Th17 cells and promotes the differentiation of Treg cells, and is useful for preventing and treating the Th17-mediated diseases including multiple sclerosis, rheumarthritis, systemic lupus erythematosus, inflammatory bowel disease, and Crohn's disease. [Reference numerals] (AA) Normal control group